z-logo
Premium
Antibiotic Prophylaxis with a Single Dose of Cefazolin During Pacemaker Implantation: Incidence of Long‐Term Infective Complications
Author(s) -
BERTAGLIA EMANUELE,
ZERBO FRANCESCA,
ZARDO SUSANNA,
BARZAN DANIELA,
ZOPPO FRANCO,
PASCOTTO PIETRO
Publication year - 2006
Publication title -
pacing and clinical electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 101
eISSN - 1540-8159
pISSN - 0147-8389
DOI - 10.1111/j.1540-8159.2006.00294.x
Subject(s) - medicine , cefazolin , infective endocarditis , antibiotic prophylaxis , surgery , incidence (geometry) , antibiotics , complication , anesthesia , physics , optics , microbiology and biotechnology , biology
Objective: Systemic and localized infections related to permanent pacemaker implantation are not common, but are serious and potentially life‐threatening complications. The aims of this prospective observational study were: (1) to assess the safety and long‐term efficacy of a simplified scheme of antibiotic prophylaxis, and (2) to identify the predictors of long‐term infective complications, in patients undergoing pacemaker implantation or replacement.Methods and Results: From October 1998 to July 2001, 852 patients (mean age 77.0 ± 9.2 years; 474 men) who underwent new permanent pacemaker implantation (69.6%) or pulse generator replacement (30.4%) received a mini‐bag of 2 g of cefazolin diluted in 50 mL of saline solution, administered intravenously in 20 minutes before the beginning of the procedure. Early (within 2 months of implantation) and late major and minor infective complications were recorded. During the earlier phase, minor complications were observed in 9 patients (1%). During the long‐term phase of the surveillance (mean 25.6 ± 11.0 months, range 12–55 months) major infective complications were observed in 6 patients (0.7%). On multivariate analysis, no clinical or procedural variable predicted the occurrence of long‐term infective complications.Conclusions: Our data indicate the safety and efficacy of a single, intravenous 2 g dose of cefazolin in preventing infective complications related to pacemaker implantation or replacement. No clinical or procedural variable predicted the occurrence of long‐term infective complications.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here